Analytical technology company AB SCIEX is to collaborate with the University of Geneva's Mass Spectrometry Centre to create new workflows and analytical strategies intended to improve drug discovery and development.
Analytical technology company AB SCIEX is to collaborate with the University of Geneva’s Mass Spectrometry Centre to create new workflows and analytical strategies intended to improve drug discovery and development. This collaboration is focused on developing specific applications for use with a mass spectrometry system from the company that it claims combines both qualitative and quantitative analysis at high resolution and high sensitivity with accurate mass.
“This new innovation, which is supported by strategies for metabolite identification developed in collaboration with the University of Geneva, will provide the pharmaceutical industry with a unique workflow solution to improve drug discovery and development”, said Laura Lauman, the company’s president, in a statement.
The mass spectrometry centre will apply the technology for metabolite identification. Having the capabilities to simultaneously identify metabolites with high resolution accurate mass and quantify them with high sensitivity would allow the scientists in Geneva to develop advanced workflows and software applications that are expected to help accelerate the adoption of the new platform within the pharmaceutical industry.
“The ability to integrate qualitative and quantitative analysis within a single platform enables new and better ways to think about conducting experiments. By developing novel workflows to take advantage of the new platform, we will be able to better understand biological systems and improve the drug discovery process”, said Gerard Hopfgartner, professor and scientist at the university, in a statement.
For more information on the company visit www.absciex.com
Inside the Laboratory: The Gionfriddo Group at the University at Buffalo
March 28th 2024In this edition of “Inside the Laboratory,” Emanuela Gionfriddo, PhD, an associate professor of chemistry at the University at Buffalo, discusses her group’s current research endeavors, including using solid-phase microextraction (SPME) coupled to liquid chromatography (LC) and gas chromatography (GC) to further understand the chemical relationship between environmental exposure and disease and elucidate micropollutants fate in the environment and biological systems.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.